Revisione narrativa dei risultati degli studi clinici controllati sull'efficacia della supplementazione con folati nel migliorare 1'esito della gravidanza

Translated title of the contribution: Effects of folic acid supplementation on pregnancy outcomes: A review of randomized clinical trials

F. Chiaffarino, G. B. Ascone, R. Bortolus, P. Mastroiacovo, E. Ricci, S. Cipriani, F. Parazzini

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Despite the causal association between defects of the metabolism of the folate (hyperhomocysteinemia) and risk of neural tube defects are both well documented, the association between folate deficiency and other pregnancy pathologies is still not entirely clear. The present article aims to gather the data published about the relationship between serum folate and pregnancy pathologies, distinguishing between the evidences emerged from the observational studies and the results of the clinical trials. We carried out a brief examination of the relationships between folate metabolism and homocysteine. Observational studies have suggested that a good level of folate in pregnancy is associated with higher birthweight, increased placental weight and fewer preterm birth. These results were not entirely consistent with findings from clinical trials. We have identified 12 randomized clinical studies with folate supplementation versus placebo. In the clinical studies where folic acid (FA) could improve pregnancy outcomes, its effect was not statistically significant, except for three studies where FA showed a significant decrease of low birthweight. With regard to preterm birth, pre-eclampsia and abruptio placentae, although in some observational studies AF was found to be associated with a reduction of these adverse outcomes, in currenty available controlled clinical trials, FA supplementation had no statistically significant effects.

Original languageItalian
Pages (from-to)293-301
Number of pages9
JournalMinerva Ginecologica
Volume62
Issue number4
Publication statusPublished - Aug 2010

Fingerprint

Pregnancy Outcome
Folic Acid
Randomized Controlled Trials
Observational Studies
Premature Birth
Pregnancy
Clinical Trials
Pathology
Abruptio Placentae
Hyperhomocysteinemia
Neural Tube Defects
Controlled Clinical Trials
Homocysteine
Pre-Eclampsia
Placebos
Weights and Measures
Serum

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Revisione narrativa dei risultati degli studi clinici controllati sull'efficacia della supplementazione con folati nel migliorare 1'esito della gravidanza. / Chiaffarino, F.; Ascone, G. B.; Bortolus, R.; Mastroiacovo, P.; Ricci, E.; Cipriani, S.; Parazzini, F.

In: Minerva Ginecologica, Vol. 62, No. 4, 08.2010, p. 293-301.

Research output: Contribution to journalArticle

@article{1e5b16c4617742f2a36e14a998c33fdc,
title = "Revisione narrativa dei risultati degli studi clinici controllati sull'efficacia della supplementazione con folati nel migliorare 1'esito della gravidanza",
abstract = "Despite the causal association between defects of the metabolism of the folate (hyperhomocysteinemia) and risk of neural tube defects are both well documented, the association between folate deficiency and other pregnancy pathologies is still not entirely clear. The present article aims to gather the data published about the relationship between serum folate and pregnancy pathologies, distinguishing between the evidences emerged from the observational studies and the results of the clinical trials. We carried out a brief examination of the relationships between folate metabolism and homocysteine. Observational studies have suggested that a good level of folate in pregnancy is associated with higher birthweight, increased placental weight and fewer preterm birth. These results were not entirely consistent with findings from clinical trials. We have identified 12 randomized clinical studies with folate supplementation versus placebo. In the clinical studies where folic acid (FA) could improve pregnancy outcomes, its effect was not statistically significant, except for three studies where FA showed a significant decrease of low birthweight. With regard to preterm birth, pre-eclampsia and abruptio placentae, although in some observational studies AF was found to be associated with a reduction of these adverse outcomes, in currenty available controlled clinical trials, FA supplementation had no statistically significant effects.",
keywords = "Abortion spontaneous Premature birth, Folic acid, Pre-eclampsia",
author = "F. Chiaffarino and Ascone, {G. B.} and R. Bortolus and P. Mastroiacovo and E. Ricci and S. Cipriani and F. Parazzini",
year = "2010",
month = "8",
language = "Italian",
volume = "62",
pages = "293--301",
journal = "Minerva Ginecologica",
issn = "0026-4784",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - Revisione narrativa dei risultati degli studi clinici controllati sull'efficacia della supplementazione con folati nel migliorare 1'esito della gravidanza

AU - Chiaffarino, F.

AU - Ascone, G. B.

AU - Bortolus, R.

AU - Mastroiacovo, P.

AU - Ricci, E.

AU - Cipriani, S.

AU - Parazzini, F.

PY - 2010/8

Y1 - 2010/8

N2 - Despite the causal association between defects of the metabolism of the folate (hyperhomocysteinemia) and risk of neural tube defects are both well documented, the association between folate deficiency and other pregnancy pathologies is still not entirely clear. The present article aims to gather the data published about the relationship between serum folate and pregnancy pathologies, distinguishing between the evidences emerged from the observational studies and the results of the clinical trials. We carried out a brief examination of the relationships between folate metabolism and homocysteine. Observational studies have suggested that a good level of folate in pregnancy is associated with higher birthweight, increased placental weight and fewer preterm birth. These results were not entirely consistent with findings from clinical trials. We have identified 12 randomized clinical studies with folate supplementation versus placebo. In the clinical studies where folic acid (FA) could improve pregnancy outcomes, its effect was not statistically significant, except for three studies where FA showed a significant decrease of low birthweight. With regard to preterm birth, pre-eclampsia and abruptio placentae, although in some observational studies AF was found to be associated with a reduction of these adverse outcomes, in currenty available controlled clinical trials, FA supplementation had no statistically significant effects.

AB - Despite the causal association between defects of the metabolism of the folate (hyperhomocysteinemia) and risk of neural tube defects are both well documented, the association between folate deficiency and other pregnancy pathologies is still not entirely clear. The present article aims to gather the data published about the relationship between serum folate and pregnancy pathologies, distinguishing between the evidences emerged from the observational studies and the results of the clinical trials. We carried out a brief examination of the relationships between folate metabolism and homocysteine. Observational studies have suggested that a good level of folate in pregnancy is associated with higher birthweight, increased placental weight and fewer preterm birth. These results were not entirely consistent with findings from clinical trials. We have identified 12 randomized clinical studies with folate supplementation versus placebo. In the clinical studies where folic acid (FA) could improve pregnancy outcomes, its effect was not statistically significant, except for three studies where FA showed a significant decrease of low birthweight. With regard to preterm birth, pre-eclampsia and abruptio placentae, although in some observational studies AF was found to be associated with a reduction of these adverse outcomes, in currenty available controlled clinical trials, FA supplementation had no statistically significant effects.

KW - Abortion spontaneous Premature birth

KW - Folic acid

KW - Pre-eclampsia

UR - http://www.scopus.com/inward/record.url?scp=78650744048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650744048&partnerID=8YFLogxK

M3 - Articolo

C2 - 20827247

AN - SCOPUS:78650744048

VL - 62

SP - 293

EP - 301

JO - Minerva Ginecologica

JF - Minerva Ginecologica

SN - 0026-4784

IS - 4

ER -